• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

揭开化脓性汗腺炎活动的面纱:一项评估[锝]锝-抗肿瘤坏死因子-α闪烁扫描术潜力的初步研究。

Shedding Light on Hidradenitis Suppurativa Activity: A Pilot Study to Evaluate the Potential of [Tc]Tc-Anti-TNF-Alpha Scintigraphy.

作者信息

da Cunha José Marcos Telles, Gutfilen-Schlesinger Gabriel, Trope Beatriz Moritz, Lopes Flávia Paiva Proença Lobo, de Souza Sergio Augusto Lopes, Gutfilen Bianca

机构信息

Department of Internal Medicine, Dermatology Service, Medical School, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-913, Brazil.

Laboratório de Marcação de Células e Moléculas (LMCM), Radiology Department, Medical School, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-913, Brazil.

出版信息

Pharmaceuticals (Basel). 2025 Aug 12;18(8):1190. doi: 10.3390/ph18081190.

DOI:10.3390/ph18081190
PMID:40872580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12389310/
Abstract

Shedding light on Hidradenitis Suppurativa activity: a pilot study to evaluate the potential of [Tc]Tc-anti-TNF-alpha scintigraphy. : Hidradenitis suppurativa (HS), also known as acne inversa and Verneuil's disease, is a chronic and non-contagious auto-inflammatory disease of pilo-sebaceous units that can lead to severe complications and sequelae. The actual prevalence of HS is unknown due to diagnostic delay and/or misdiagnosis, but it is estimated to affect 0.00033-4.1% of the general population worldwide. Only severe cases are referred for imaging assessment, and the final diagnosis is mostly established on a clinical basis. Here, we present a pilot study aiming to evaluate clinically active inflammatory disease in patients with HS using [Tc]Tc-anti-TNF-alpha scintigraphy. : Four patients (2 male, 2 female) had their HS clinical features measured through the HS-PGA and Hurley Score and compared to [Tc]Tc-anti-TNF-alpha scintigraphy findings. : Scintigraphy with [Tc]Tc-anti-TNF-alpha showed abnormal uptake in clinically active lesions of HS and also detected some clinically unknown potential active lesions, later confirmed by clinical reassessment after the imaging. : Our results suggest that scintigraphy with [Tc]Tc-anti-TNF-alpha may be able to detect increased radiotracer uptake in most clinically identified active lesions in this pilot cohort. While promising, due to the inherent limitations of this pilot study, more studies need to be carried out to arrive at a definitive diagnostic assessment of active inflammatory disease using this method.

摘要

揭开化脓性汗腺炎活动情况的面纱

一项评估[锝]Tc-抗TNF-α闪烁显像潜力的初步研究 :化脓性汗腺炎(HS),也称为反向性痤疮和韦尔内伊病,是一种毛囊皮脂腺单位的慢性非传染性自身炎症性疾病,可导致严重并发症和后遗症。由于诊断延迟和/或误诊,HS的实际患病率尚不清楚,但据估计全球普通人群中受其影响的比例为0.00033%-4.1%。只有重症病例才会接受影像学评估,最终诊断大多基于临床。在此,我们开展了一项初步研究,旨在使用[锝]Tc-抗TNF-α闪烁显像评估HS患者的临床活动性炎症性疾病。 :四名患者(2名男性,2名女性)通过HS-PGA和赫尔利评分对其HS临床特征进行了测量,并与[锝]Tc-抗TNF-α闪烁显像结果进行了比较。 :[锝]Tc-抗TNF-α闪烁显像显示HS临床活动性病变中有异常摄取,还检测到一些临床未知的潜在活动性病变,成像后经临床重新评估得到证实。 :我们的结果表明,[锝]Tc-抗TNF-α闪烁显像可能能够在这个初步队列中的大多数临床确定的活动性病变中检测到放射性示踪剂摄取增加。虽然前景乐观,但由于这项初步研究的固有局限性,需要开展更多研究,以便使用这种方法对活动性炎症性疾病进行明确的诊断评估。

相似文献

1
Shedding Light on Hidradenitis Suppurativa Activity: A Pilot Study to Evaluate the Potential of [Tc]Tc-Anti-TNF-Alpha Scintigraphy.揭开化脓性汗腺炎活动的面纱:一项评估[锝]锝-抗肿瘤坏死因子-α闪烁扫描术潜力的初步研究。
Pharmaceuticals (Basel). 2025 Aug 12;18(8):1190. doi: 10.3390/ph18081190.
2
Psychometric validation and interpretation thresholds of the Hidradenitis Suppurativa Quality of Life (HiSQOL©) questionnaire using pooled data from the phase III BE HEARD I & II trials of bimekizumab in hidradenitis suppurativa.使用比美吉珠单抗治疗化脓性汗腺炎的III期BE HEARD I和II试验的汇总数据,对化脓性汗腺炎生活质量(HiSQOL©)问卷进行心理测量学验证和解释阈值分析。
Br J Dermatol. 2025 Jun 20;193(1):93-104. doi: 10.1093/bjd/ljaf067.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
6
Validation of the real-world application of the Hidradenitis Suppurativa Quality of Life (HiSQOL) score to adults with hidradenitis suppurativa.化脓性汗腺炎生活质量(HiSQOL)评分在成年化脓性汗腺炎患者真实世界应用中的验证。
Br J Dermatol. 2025 Jan 24;192(2):261-268. doi: 10.1093/bjd/ljae367.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
8
A qualitative interview study exploring patients' views and experiences of treatment for hidradenitis suppurativa in the UK.一项定性访谈研究,探讨英国化脓性汗腺炎患者对治疗的看法和经历。
Br J Dermatol. 2025 Jun 20;193(1):85-92. doi: 10.1093/bjd/ljaf046.
9
The roles of interleukin (IL)-17A and IL-17F in hidradenitis suppurativa pathogenesis: evidence from human in vitro preclinical experiments and clinical samples.白细胞介素(IL)-17A和IL-17F在化脓性汗腺炎发病机制中的作用:来自人体体外临床前实验和临床样本的证据
Br J Dermatol. 2025 Mar 18;192(4):660-671. doi: 10.1093/bjd/ljae442.
10
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.用于诊断神经母细胞瘤的123I-间碘苄胍闪烁扫描术和18F-氟代脱氧葡萄糖正电子发射断层显像
Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD009263. doi: 10.1002/14651858.CD009263.pub2.

本文引用的文献

1
The Role of FDG-PET in the Evaluation of Hidradenitis Suppurativa: A Systematic Review.18F-氟脱氧葡萄糖正电子发射断层扫描在化脓性汗腺炎评估中的作用:一项系统评价
J Clin Med. 2023 Aug 24;12(17):5491. doi: 10.3390/jcm12175491.
2
Incidence, Risk Factors, and Prognosis of Hidradenitis Suppurativa Across the Globe: Insights from the Literature.全球化脓性汗腺炎的发病率、危险因素及预后:文献综述
Clin Cosmet Investig Dermatol. 2023 Mar 2;16:545-552. doi: 10.2147/CCID.S402453. eCollection 2023.
3
Gadolinium-Based Contrast Agents: Updates and Answers to Typical Questions Regarding Gadolinium Use.
钆基造影剂:有关钆使用的常见问题的最新解答。
Tex Heart Inst J. 2022 May 1;49(3). doi: 10.14503/THIJ-21-7680.
4
Should We Scan Hidradenitis Suppurativa Patients? A Systematic Review of Radiologic Findings.我们是否应该对化脓性汗腺炎患者进行扫描?影像学表现的系统评价。
Adv Skin Wound Care. 2021 Jul 1;34(7):1-10. doi: 10.1097/01.ASW.0000753196.64470.6a.
5
99mTc-antitumor necrosis factor-alpha scintigraphy for the detection of inflammatory activity in rheumatoid arthritis.99mTc-抗肿瘤坏死因子-α闪烁显像用于检测类风湿关节炎的炎症活动。
Nucl Med Commun. 2021 Apr 1;42(4):389-395. doi: 10.1097/MNM.0000000000001333.
6
The epidemiology of hidradenitis suppurativa.化脓性汗腺炎的流行病学
Br J Dermatol. 2020 Dec;183(6):990-998. doi: 10.1111/bjd.19435. Epub 2020 Sep 3.
7
Immunopathogenesis of hidradenitis suppurativa and response to anti-TNF-α therapy.化脓性汗腺炎的免疫发病机制和抗 TNF-α 治疗反应。
JCI Insight. 2020 Oct 2;5(19):139932. doi: 10.1172/jci.insight.139932.
8
Paradoxical Hidradenitis Suppurativa in Patients Receiving TNF-α Inhibitors: Case Series, Systematic Review, and Case Meta-Analysis.接受 TNF-α 抑制剂治疗的患者中出现矛盾性化脓性汗腺炎:病例系列、系统评价和病例荟萃分析。
Dermatology. 2020;236(4):307-313. doi: 10.1159/000506074. Epub 2020 Mar 5.
9
TNF-α inhibitors in the treatment of hidradenitis suppurativa.肿瘤坏死因子-α抑制剂在化脓性汗腺炎治疗中的应用
Ther Adv Chronic Dis. 2019 May 27;10:2040622319851640. doi: 10.1177/2040622319851640. eCollection 2019.
10
Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trials.阿达木单抗在中重度化脓性汗腺炎中的中期剂量策略:来自 III 期随机安慰剂对照 PIONEER 试验的综合结果。
Br J Dermatol. 2019 Nov;181(5):967-975. doi: 10.1111/bjd.17919. Epub 2019 Aug 14.